These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 21154140)

  • 41. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNAs and other small silencing RNAs in cancer.
    Rovira C; Güida MC; Cayota A
    IUBMB Life; 2010 Dec; 62(12):859-68. PubMed ID: 21154820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of miRNA in carcinogenesis and biomarker selection: a methodological view.
    Ahmed FE
    Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of microRNAs for potential cancer therapeutics.
    Wu W
    Methods Mol Biol; 2011; 676():59-70. PubMed ID: 20931390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNAs in cancer: personalizing diagnosis and therapy.
    Nana-Sinkam SP; Fabbri M; Croce CM
    Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
    Metias SM; Lianidou E; Yousef GM
    J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy.
    Ozek NS; Tuna S; Erson-Bensan AE; Severcan F
    Analyst; 2010 Dec; 135(12):3094-102. PubMed ID: 20978686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential of microRNAs for cancer diagnostics, prognostication and therapy.
    Garzon R; Marcucci G
    Curr Opin Oncol; 2012 Nov; 24(6):655-9. PubMed ID: 23079782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers.
    Nugent M; Miller N; Kerin MJ
    Eur J Surg Oncol; 2011 Aug; 37(8):649-54. PubMed ID: 21632200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNAs as new therapeutic targets and tools in cancer.
    Gandellini P; Profumo V; Folini M; Zaffaroni N
    Expert Opin Ther Targets; 2011 Mar; 15(3):265-79. PubMed ID: 21208133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.
    Wang H; Jiang Y; Peng H; Chen Y; Zhu P; Huang Y
    Adv Drug Deliv Rev; 2015 Jan; 81():142-60. PubMed ID: 25450259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential.
    Chistiakov DA; Chekhonin VP
    Eur J Pharmacol; 2012 Jun; 684(1-3):8-18. PubMed ID: 22484336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiRNAs in cancer: non-coding RNAs as appealing biomarkers for malignancy.
    Morin P
    Cancer Biomark; 2012; 11(6):227-8. PubMed ID: 23248179
    [No Abstract]   [Full Text] [Related]  

  • 54. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
    Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
    Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers.
    Dai X; Tan C
    Adv Drug Deliv Rev; 2015 Jan; 81():184-97. PubMed ID: 25281917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.
    Rupaimoole R; Slack FJ
    Nat Rev Drug Discov; 2017 Mar; 16(3):203-222. PubMed ID: 28209991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNAs: novel mediators of resistance to microtubule-targeting agents.
    Kanakkanthara A; Miller JH
    Cancer Treat Rev; 2013 Apr; 39(2):161-70. PubMed ID: 22902296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.
    Kaboli PJ; Rahmat A; Ismail P; Ling KH
    Pharmacol Res; 2015 Jul; 97():104-21. PubMed ID: 25958353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-coding RNAs: Therapeutic Strategies and Delivery Systems.
    Ling H
    Adv Exp Med Biol; 2016; 937():229-37. PubMed ID: 27573903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [MicroRNA and hypertension].
    Duan L; Xiong XJ; Wang J
    Zhongguo Zhong Yao Za Zhi; 2014 Feb; 39(3):397-401. PubMed ID: 24946537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.